HCW Biologics (HCWB)
HCW Biologics on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
38K
Short interest
settlement 2026-10-15
1.0
Days to cover
unchanged vs prior
82.4%
Short share of volume
2026-11-02
32
Fails to deliver
settlement 2026-10-09
Fri 13 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in HCWB is 37,709 shares, up 28,435 shares over the last month. Over the last 48 readings it ranged from 6,925 shares (30 April 2025) to 3,844,753 shares (15 May 2026). The latest reading sits at the bottom of that range. At the reported average volume of 226K shares a day that is 1.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/hcwb" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 37,709 | -38.1% | 226,124 | 1.00 |
| 2026-09-30 | 60,941 | +557.1% | 1,348,961 | 1.00 |
| 2026-09-15 | 9,274 | -72.8% | 414,337 | 1.00 |
| 2026-08-31 | 34,136 | +137.9% | 238,774 | 1.00 |
| 2026-08-14 | 14,348 | -31.6% | 80,165 | 1.00 |
| 2026-07-31 | 20,979 | -30.0% | 71,092 | 1.00 |
| 2026-07-15 | 29,960 | -28.2% | 46,266 | 1.00 |
| 2026-06-30 | 41,709 | -86.0% | 197,573 | 1.00 |
| 2026-06-15 | 296,814 | -29.0% | 1,119,234 | 1.00 |
| 2026-05-29 | 417,960 | -89.1% | 32,633,321 | 1.00 |
| 2026-05-15 | 3,844,753 | +573.5% | 39,013,224 | 1.00 |
| 2026-04-30 | 570,862 | +337.1% | 3,361,130 | 1.00 |
| 2026-04-15 | 130,618 | +18.1% | 617,310 | 1.00 |
| 2026-03-31 | 110,641 | +158.1% | 41,337,246 | 1.00 |
| 2026-03-13 | 42,868 | -25.6% | 110,390 | 1.00 |
| 2026-02-27 | 57,608 | +142.5% | 163,691 | 1.00 |
| 2026-02-13 | 23,758 | -56.0% | 115,610 | 1.00 |
| 2026-01-30 | 53,964 | +151.7% | 93,084 | 1.00 |
| 2026-01-15 | 21,438 | +59.8% | 42,653 | 1.00 |
| 2025-12-31 | 13,416 | -78.6% | 65,324 | 1.00 |
| 2025-12-15 | 62,738 | +457.9% | 50,488 | 1.24 |
| 2025-11-28 | 11,245 | -78.0% | 87,704 | 1.00 |
| 2025-11-14 | 51,075 | +13.3% | 203,602 | 1.00 |
| 2025-10-31 | 45,074 | -49.7% | 34,725 | 1.30 |
| 2025-10-15 | 89,586 | +9.2% | 136,717 | 1.00 |
| 2025-09-30 | 82,043 | -76.6% | 107,993 | 1.00 |
| 2025-09-15 | 350,555 | +42.9% | 2,502,196 | 1.00 |
| 2025-08-29 | 245,390 | +542.0% | 9,027,921 | 1.00 |
| 2025-08-15 | 38,223 | -50.9% | 23,281 | 1.64 |
| 2025-07-31 | 77,824 | +50.0% | 171,221 | 1.00 |
| 2025-07-15 | 51,880 | -66.0% | 38,130 | 1.36 |
| 2025-06-30 | 152,602 | +1070.8% | 435,786 | 1.00 |
| 2025-06-13 | 13,034 | -68.0% | 44,732 | 1.00 |
| 2025-05-30 | 40,678 | -85.9% | 154,162 | 1.00 |
| 2025-05-15 | 288,435 | +4065.1% | 3,536,076 | 1.00 |
| 2025-04-30 | 6,925 | -22.1% | 21,822 | 1.00 |
| 2025-04-15 | 8,895 | -97.7% | 8,858 | 1.00 |
| 2025-03-31 | 390,944 | -13.2% | 91,078 | 4.29 |
| 2025-03-14 | 450,173 | -17.2% | 132,475 | 3.40 |
| 2025-02-28 | 543,708 | -34.9% | 179,687 | 3.03 |
| 2025-02-14 | 835,487 | +905.3% | 36,236,163 | 1.00 |
| 2025-01-31 | 83,110 | +50.8% | 307,237 | 1.00 |
| 2025-01-15 | 55,119 | -57.9% | 177,249 | 1.00 |
| 2024-12-31 | 131,012 | -43.6% | 394,740 | 1.00 |
| 2024-12-13 | 232,108 | +80.0% | 466,074 | 1.00 |
| 2024-11-29 | 128,933 | -10.9% | 64,200,638 | 1.00 |
| 2024-11-15 | 144,731 | +1688.6% | 152,427 | 1.00 |
| 2024-10-31 | 8,092 | -67.5% | 29,475 | 1.00 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of HCWB volume is 82.4%, up 73.2 points over the last five sessions. Over the last 30 readings it ranged from 8.5% (22 October 2026) to 82.4% (2 November 2026). The latest reading sits at the top of that range. The latest reading is 42.0 points above the 30-session average of 40.4%, on 53K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 43K | 53K | 82.4% | 1 |
| 2026-10-30 | 8K | 24K | 31.9% | 0 |
| 2026-10-29 | 21K | 28K | 76.6% | 0 |
| 2026-10-28 | 6K | 16K | 36.7% | 0 |
| 2026-10-27 | 2K | 9K | 26.9% | 0 |
| 2026-10-26 | 2K | 21K | 9.2% | 0 |
| 2026-10-23 | 9K | 28K | 30.8% | 0 |
| 2026-10-22 | 2K | 20K | 8.5% | 0 |
| 2026-10-21 | 10K | 22K | 43.2% | 0 |
| 2026-10-20 | 18K | 34K | 52.6% | 0 |
| 2026-10-19 | 5K | 25K | 21.6% | 0 |
| 2026-10-16 | 15K | 26K | 59.6% | 0 |
| 2026-10-15 | 9K | 22K | 42.2% | 0 |
| 2026-10-14 | 5K | 24K | 22.9% | 182 |
| 2026-10-13 | 48K | 126K | 38.0% | 10,937 |
| 2026-10-12 | 4K | 16K | 23.9% | 300 |
| 2026-10-09 | 8K | 24K | 34.3% | 57 |
| 2026-10-08 | 5K | 19K | 24.2% | 180 |
| 2026-10-07 | 10K | 14K | 74.3% | 0 |
| 2026-10-06 | 4K | 11K | 34.8% | 0 |
| 2026-10-05 | 6K | 24K | 23.7% | 0 |
| 2026-10-02 | 21K | 33K | 63.8% | 0 |
| 2026-10-01 | 10K | 24K | 40.4% | 0 |
| 2026-09-30 | 4K | 27K | 14.0% | 0 |
| 2026-09-29 | 8K | 28K | 30.3% | 1,530 |
| 2026-09-28 | 24K | 49K | 48.6% | 3,006 |
| 2026-09-25 | 38K | 164K | 23.1% | 314 |
| 2026-09-24 | 5.3M | 8.9M | 59.6% | 1,017,935 |
| 2026-09-23 | 58K | 83K | 70.4% | 6,946 |
| 2026-09-22 | 26K | 42K | 62.9% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 9 October 2026, the fails-to-deliver balance in HCWB is 32 shares, down 1,555 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (6 August 2026) to 86,085 shares (25 September 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-09 | 32 | $1.53 | $49 |
| 2026-10-05 | 1,587 | $1.68 | $3K |
| 2026-10-02 | 236 | $1.69 | $399 |
| 2026-10-01 | 107 | $1.71 | $183 |
| 2026-09-30 | 2,326 | $1.75 | $4K |
| 2026-09-29 | 15,506 | $1.82 | $28K |
| 2026-09-28 | 39,707 | $1.93 | $77K |
| 2026-09-25 | 86,085 | $1.99 | $171K |
| 2026-09-22 | 13 | $1.91 | $25 |
| 2026-09-17 | 3,449 | $2.01 | $7K |
| 2026-09-11 | 21,988 | $2.43 | $53K |
| 2026-09-10 | 29,544 | $2.46 | $73K |
| 2026-09-09 | 41,072 | $2.51 | $103K |
| 2026-09-01 | 10,172 | $3.59 | $37K |
| 2026-08-31 | 14,161 | $3.43 | $49K |
| 2026-08-28 | 50,299 | $3.17 | $159K |
| 2026-08-27 | 22,368 | $2.70 | $60K |
| 2026-08-26 | 32,397 | $2.60 | $84K |
| 2026-08-25 | 8,596 | $2.31 | $20K |
| 2026-08-24 | 3,235 | $2.18 | $7K |
| 2026-08-21 | 1 | $2.12 | $2 |
| 2026-08-20 | 1 | $2.30 | $2 |
| 2026-08-18 | 366 | $2.52 | $922 |
| 2026-08-17 | 8,963 | $2.68 | $24K |
| 2026-08-07 | 1 | $3.41 | $3 |
| 2026-08-06 | 1 | $3.43 | $3 |
| 2026-08-04 | 1,273 | $3.34 | $4K |
| 2026-08-03 | 3,844 | $3.20 | $12K |
| 2026-07-31 | 4,400 | $3.15 | $14K |
| 2026-07-30 | 875 | $2.58 | $2K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for HCWB in the last 90 days. The most recent filings are listed below. Latest filing: Wong Hing C (Chief Executive Officer) on 2026-07-29.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-07-29 | Wong Hing C | Chief Executive Officer | Buy | 23K | $2.58 | $60K | 126K |
| 2026-07-29 | GARRETT SCOTT T | Director | Buy | 8K | $2.58 | $20K | 42K |
| 2026-07-29 | Flowers Lee | SVP of Business Development | Buy | 8K | $2.58 | $20K | 9K |
| 2026-05-22 | Wong Hing C | Chief Executive Officer | Buy | 114K | $1.41 | $160K | 616K |
| 2026-05-22 | GARRETT SCOTT T | Director | Buy | 178K | $1.41 | $250K | 203K |
| 2026-05-22 | Byam Rebecca | Chief Financial Officer | Buy | 14K | $1.41 | $20K | 57K |
| 2025-05-16 | GARRETT SCOTT T | Director | Buy | 13K | $7.45 | $100K | 26K |
| 2025-05-16 | Winer Gary M | Director | Buy | 1K | $7.45 | $10K | 4K |
| 2025-05-16 | Wong Hing C | Chief Executive Officer | Buy | 8K | $7.45 | $60K | 502K |
| 2025-05-08 | Greene Rick S. | Director | Buy | 962 | $26.00 | $25K | 2K |
| 2025-05-08 | Flowers Lee | SVP of Business Development | Buy | 962 | $26.00 | $25K | 6K |
| 2025-05-08 | Byam Rebecca | Chief Financial Officer | Buy | 8K | $26.00 | $220K | 43K |
| 2025-05-08 | GARRETT SCOTT T | Director | Buy | 5K | $26.00 | $140K | 12K |
| 2025-05-08 | Wong Hing C | Chief Executive Officer | Buy | 93K | $26.00 | $2.4M | 494K |
| 2025-05-08 | Winer Gary M | Director | Buy | 2K | $26.00 | $60K | 3K |
| 2024-02-20 | Byam Rebecca | Chief Financial Officer | Grant | 761K | $1.40 | $1.1M | 1.4M |
| 2024-02-20 | Flowers Lee | SVP of Business Development | Grant | 71K | $1.40 | $100K | 190K |
| 2024-02-20 | GARRETT SCOTT T | Director | Grant | 143K | $1.40 | $200K | 268K |
| 2024-02-20 | Giles Lisa M. | Director | Grant | 36K | $1.40 | $50K | 36K |
| 2024-02-20 | Greene Rick S. | Director | Grant | 36K | $1.40 | $50K | 44K |
| 2024-02-20 | Wong Hing C | Chief Executive Officer | Grant | 739K | $1.40 | $1.0M | 16.1M |
| 2023-12-11 | Rhode Peter | See Remarks | Exercise or conversion | 14K | $0.14 | $2K | 78K |
| 2023-12-08 | Flowers Lee | SVP of Business Development | Exercise or conversion | 8K | $0.14 | $1K | 119K |
| 2023-11-17 | Rhode Peter | See Remarks | Exercise or conversion | 15K | $0.14 | $2K | 64K |
| 2023-10-19 | Byam Rebecca | Chief Financial Officer | Exercise or conversion | 47K | $0.14 | $7K | 621K |
| 2023-09-14 | Winer Gary M | Director | Buy | 162 | $2.08 | $337 | 16K |
| 2023-09-14 | Winer Gary M | Director | Buy | 879 | $2.05 | $2K | 17K |
| 2023-09-14 | Wong Hing C | Chief Executive Officer | Buy | 2K | $2.08 | $4K | 15.3M |
| 2023-09-13 | Byam Rebecca | Chief Financial Officer | Buy | 5K | $2.10 | $11K | 574K |
| 2023-09-13 | Winer Gary M | Director | Buy | 46 | $2.00 | $92 | 16K |
| 2023-09-13 | Winer Gary M | Director | Buy | 500 | $2.05 | $1K | 16K |
| 2023-09-12 | Winer Gary M | Director | Buy | 500 | $2.05 | $1K | 15K |
| 2023-09-12 | Byam Rebecca | Chief Financial Officer | Buy | 5K | $2.09 | $10K | 569K |
| 2023-09-11 | Winer Gary M | Director | Buy | 99 | $2.05 | $203 | 15K |
| 2023-09-11 | Byam Rebecca | Chief Financial Officer | Buy | 5K | $2.05 | $10K | 564K |
| 2023-09-08 | Byam Rebecca | Chief Financial Officer | Buy | 5K | $2.02 | $10K | 559K |
| 2023-09-08 | Winer Gary M | Director | Buy | 1 | $1.90 | $2 | 15K |
| 2023-09-07 | Winer Gary M | Director | Buy | 63 | $1.95 | $123 | 15K |
| 2023-09-07 | Byam Rebecca | Chief Financial Officer | Buy | 5K | $1.95 | $10K | 554K |
| 2023-09-06 | Byam Rebecca | Chief Financial Officer | Buy | 5K | $1.95 | $10K | 549K |
| 2023-09-05 | Winer Gary M | Director | Buy | 400 | $1.75 | $700 | 15K |
| 2023-06-09 | Byam Rebecca | Chief Financial Officer | Buy | 20K | $2.06 | $41K | 544K |
| 2023-06-08 | Byam Rebecca | Chief Financial Officer | Buy | 5K | $2.21 | $10K | 524K |
| 2023-06-08 | Flowers Lee | SVP of Business Development | Exercise or conversion | 5K | $0.14 | $750 | 101K |
| 2023-06-08 | Flowers Lee | SVP of Business Development | Buy | 10K | $2.16 | $22K | 111K |
| 2023-06-07 | Byam Rebecca | Chief Financial Officer | Buy | 20K | $2.03 | $41K | 519K |
| 2023-06-06 | Byam Rebecca | Chief Financial Officer | Buy | 19K | $1.82 | $35K | 499K |
| 2023-06-05 | Byam Rebecca | Chief Financial Officer | Buy | 20K | $1.67 | $33K | 480K |
| 2023-06-02 | Wong Hing C | Chief Executive Officer | Buy | 800 | $1.54 | $1K | 15.3M |
| 2023-06-01 | Wong Hing C | Chief Executive Officer | Buy | 800 | $1.62 | $1K | 15.3M |
| 2023-05-31 | Winer Gary M | Director | Buy | 500 | $1.50 | $750 | 14K |
| 2023-05-31 | Wong Hing C | Chief Executive Officer | Buy | 2K | $1.55 | $3K | 15.3M |
| 2023-05-30 | Winer Gary M | Director | Buy | 850 | $1.52 | $1K | 14K |
| 2023-05-30 | Wong Hing C | Chief Executive Officer | Buy | 3K | $1.55 | $5K | 15.3M |
| 2023-05-26 | Byam Rebecca | Chief Financial Officer | Buy | 20K | $1.66 | $33K | 460K |
| 2023-05-25 | Byam Rebecca | Chief Financial Officer | Buy | 20K | $1.62 | $32K | 440K |
| 2023-05-24 | Byam Rebecca | Chief Financial Officer | Buy | 20K | $1.61 | $32K | 420K |
| 2023-05-23 | Byam Rebecca | Chief Financial Officer | Buy | 5K | $1.57 | $8K | 400K |
| 2023-05-22 | Byam Rebecca | Chief Financial Officer | Buy | 33K | $1.53 | $51K | 395K |
| 2022-11-02 | Byam Rebecca | Chief Financial Officer | Exercise or conversion | 34K | $0.14 | $5K | 362K |
| 2022-09-14 | Byam Rebecca | Chief Financial Officer | Buy | 15K | $2.58 | $39K | 328K |
| 2022-09-13 | Byam Rebecca | Chief Financial Officer | Buy | 15K | $2.58 | $39K | 313K |
| 2022-09-12 | Byam Rebecca | Chief Financial Officer | Buy | 15K | $2.65 | $40K | 298K |
| 2022-09-09 | Wong Hing C | Chief Executive Officer | Buy | 6K | $2.70 | $16K | 15.3M |
| 2022-09-08 | Wong Hing C | Chief Executive Officer | Buy | 4K | $2.67 | $11K | 15.3M |
| 2022-09-07 | Wong Hing C | Chief Executive Officer | Buy | 6K | $2.58 | $15K | 15.3M |
| 2022-09-02 | Wong Hing C | Chief Executive Officer | Buy | 4K | $2.55 | $10K | 15.3M |
| 2022-08-31 | Byam Rebecca | Chief Financial Officer | Buy | 10K | $2.56 | $26K | 283K |
| 2022-08-30 | Byam Rebecca | Chief Financial Officer | Buy | 7K | $2.55 | $18K | 273K |
| 2022-08-29 | Byam Rebecca | Chief Financial Officer | Buy | 10K | $2.57 | $26K | 266K |
| 2022-08-26 | Byam Rebecca | Chief Financial Officer | Buy | 10K | $2.54 | $25K | 256K |
| 2022-08-25 | Byam Rebecca | Chief Financial Officer | Buy | 40K | $2.59 | $104K | 246K |
| 2022-08-24 | Byam Rebecca | Chief Financial Officer | Buy | 50K | $2.50 | $125K | 205K |
| 2022-06-14 | Byam Rebecca | Chief Financial Officer | Buy | 59K | $2.46 | $145K | 155K |
| 2022-06-13 | Byam Rebecca | Chief Financial Officer | Buy | 8K | $2.08 | $16K | 97K |
| 2022-06-10 | Winer Gary M | Director | Buy | 2K | $2.13 | $3K | 13K |
| 2022-06-10 | Wong Hing C | Chief Executive Officer | Buy | 2K | $2.19 | $3K | 15.3M |
| 2022-06-09 | Wong Hing C | Chief Executive Officer | Buy | 2K | $2.25 | $5K | 15.3M |
| 2022-06-09 | Winer Gary M | Director | Buy | 1K | $2.20 | $2K | 12K |
| 2022-06-08 | Winer Gary M | Director | Buy | 1K | $2.27 | $2K | 11K |
| 2022-06-07 | Winer Gary M | Director | Buy | 1K | $2.10 | $2K | 10K |
| 2022-06-07 | Wong Hing C | Chief Executive Officer | Buy | 1K | $2.31 | $2K | 15.3M |
| 2022-06-06 | Winer Gary M | Director | Buy | 1K | $2.13 | $2K | 9K |
| 2022-06-02 | Greene Rick S. | Director | Buy | 5K | $2.09 | $10K | 8K |
| 2022-05-31 | Jiao Jin-an | VP of Development | Exercise or conversion | 2K | $0.21 | $360 | 45K |
| 2022-05-31 | Jiao Jin-an | VP of Development | Exercise or conversion | 13K | $0.14 | $2K | 43K |
| 2022-01-14 | Rhode Peter | See Remarks | Exercise or conversion | 2K | $0.21 | $360 | 48K |
| 2022-01-14 | Rhode Peter | See Remarks | Exercise or conversion | 1 | $0.14 | $0 | 49K |
| 2021-12-06 | Jiao Jin-an | VP of Development | Buy | 10K | $2.42 | $24K | 31K |
| 2021-12-01 | Flowers Lee | SVP of Business Development | Exercise or conversion | 4K | $0.14 | $600 | 96K |
| 2021-11-23 | Byam Rebecca | Chief Financial Officer | Exercise or conversion | 27K | $0.14 | $4K | 89K |
| 2021-09-15 | Medmira Capital Ltd. | TenPercentOwner | Other transaction | 3.6M | $0.00 | $0 | 0 |
| 2021-08-31 | Wong Hing C | Chief Executive Officer | Buy | 6K | $3.94 | $23K | 15.3M |
| 2021-08-31 | Wong Hing C | Chief Executive Officer | Buy | 4K | $3.93 | $15K | 15.3M |
| 2021-08-30 | Wong Hing C | Chief Executive Officer | Buy | 6K | $3.93 | $24K | 15.3M |
| 2021-08-27 | Wong Hing C | Chief Executive Officer | Buy | 8K | $3.76 | $30K | 15.3M |
| 2021-08-27 | Wong Hing C | Chief Executive Officer | Buy | 6K | $3.77 | $23K | 15.3M |
| 2021-08-26 | Wong Hing C | Chief Executive Officer | Buy | 7K | $3.84 | $25K | 15.3M |
| 2021-08-25 | Greene Rick S. | Director | Buy | 4K | $4.10 | $15K | 4K |
| 2021-08-23 | Flowers Lee | SVP of Business Development | Buy | 6K | $3.95 | $22K | 92K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSONNo holder on file reports 5% or more of HCWB in its latest filing.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-05-15 | 13G/Ano. 1 | Steven Boydparent holding company, individual | 354K | 5.0% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Armistice Capital, LLCinvestment adviser, other entity | 354K | 5.0% | 2026-03-31 |
13F holders
Tracked managers holding HCWB at their latest 13F. JSON1 of the 30 tracked managers held HCWB at their latest 13F, $100K in total at quarter-end prices. Citadel Advisors is the largest at $100K (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 0 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 20K | $100K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
HCW Biologics in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows HCW Biologics (HCWB), SEC CIK 1828673, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-09.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-05-15.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-14.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-07-29.JSON and CSV
- Company record
- EDGAR filing index for CIK 1828673Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of HCWB is sold short?
37,709 shares were held short at the 2026-10-15 settlement, 1.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is HCWB's daily short volume?
On 2026-11-02, 43,353 of the 52,637 HCWB shares reported to FINRA were sold short, 82.4% of the day's reported volume. Short volume is a flow for one day, not a position.
Does HCWB have fails to deliver?
The SEC's latest file shows 32 HCWB shares failed to deliver at settlement 2026-10-09. Fails are reported per settlement date and published twice a month with a lag.
Are HCWB insiders buying or selling?
No open-market insider trades were reported for HCWB in the last 90 days. The most recent filings are listed below. Latest filing: Wong Hing C (Chief Executive Officer) on 2026-07-29.
Who owns 5% or more of HCWB?
No holder on file reports 5% or more of HCWB in its latest filing.
Which tracked 13F managers own HCWB?
1 of the 30 tracked 13F managers held HCWB shares at their latest filing, $100K in all. The largest: Ken Griffin's Citadel Advisors (20K shares, $100K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.